Sign inJoin waitlistJoin the waitlist

Minh Truong

Chief of Radiation Oncology · Boston University Medical Center

Credentials: · · · · ·

History

Radiation Oncology Division · Boston University Medical Center
Present
Radiation Oncology Division · Boston University Medical Center
Present
Boston University Medical Center
Present

Radiation Oncology
NYU Grossman School of Medicine
2000–2004
Preliminary or Transitional Year
1999–2000
University of New South Wales, MBBS
UNSW Faculty of Medicine
1993–1997

Research

Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)
Journal of Clinical Oncology · 2021 · 323 citations
18F-FDG metabolic tumor volume and total glycolytic activity of oral cavity and oropharyngeal squamous cell cancer: adding value to clinical staging
Journal of Nuclear Medicine · 2012 · 199 citations
Prone accelerated partial breast irradiation after breast-conserving surgery: preliminary clinical results and dose-volume histogram analysis
International journal of radiation oncology · 2004 · 179 citations

Scharukh Jalisi
24 papers
Osamu Sakai
19 papers
Kimberley Mak
18 papers · 6 as a resident
RS
Rathan Subramaniam
16 papers · 14 as a resident
Ariel Hirsch
15 papers · 1 as a resident
AS
Andrew Salama
14 papers
Aiven Dyer
13 papers · 1 as a resident
Gustavo Mercier
11 papers
Lisa Kachnic
10 papers
Gregory Grillone
9 papers
PR
Paul Romesser
7 papers · 7 as a resident
Samuel Rubin
7 papers · 7 as a resident

Clinical trials

Patient Navigation in Cancer Survivorship at a Safety Net Institution
Principal investigator · Completed
Boston Medical Center
2017–2020
Stereotactic Radiosurgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer
Principal investigator · Terminated
Boston Medical Center
2009–2016
Stereotactic Radiosurgery in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer
Principal investigator · Completed
Boston Medical Center
2009–2017
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Site PI · Recruiting · Phase 2
NRG Oncology
2025–2032